🔎 Trials Near Me

Dachaigh › Cancer Cervical › Massachusetts › Boston

Sgrùdaidhean clionaigeach Cancer Cervical ann an Boston, MA

Tha 18 sgrùdaidhean airson Cancer Cervical a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

A’ fastadhÌre 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06760819

Distance-Based Exercise to Preserve Function and Prevent Disability

A’ fastadh
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07059884

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A’ fastadhÌre 1/2
  • Tufts Medical Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

A’ fastadhÌre 1/2
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

A’ fastadhÌre 1
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

A’ fastadhÌre 1
  • Mass General Cancer Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07227168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

A’ fastadhÌre 1
  • Normunity Investigational Site, Boston
  • Normunity Investigational Site, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Massachusetts General Hospital Cancer Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05592626

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

A’ fastadh
  • Massachusetts General Brigham, Boston
Aoisean 21 gu 70 · Banairean · Air ùrachadh 7 Lùna 2026 · NCT06872346

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • agus 2 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04389632

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT06993844

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06239194

Building Connections

A’ fastadh
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 18 Samh 2025 · NCT07091032

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

A’ fastadhÌre 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 5 Samh 2025 · NCT06677190

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT05941507

Sgrùdaidhean Cancer Cervical ann am bailtean eile

Sgrùdaidhean eile ann an Boston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.